ZURICH and NESS ZIONA, Israel - NLS Pharmaceutics Ltd. (Nasdaq: NLSP) and Kadimastem Ltd. (TASE: KDST) announced plans for a merger, aiming to enhance diabetes treatment by combining their expertise ...

From hallucinations to swollen feet and an unexpected stop at a police station, former British soldier Harry Amos’s journey ...

Experts are now calling for NHS guidance - which does not recommend managing diabetes with different drugs depending on age - to be updated in light of the findings.